David Lee

David Lee is an accomplished leader in strategy consulting, technology, and healthcare, currently serving as the Founder and Inventor at DAETA 47. They have a US Patent Pending in Biometric Cryptography and previously held significant roles, including General Manager at nexomics and Director of Strategy at the Peter MacCallum Cancer Centre. David's extensive experience includes a dual role as the Director of Business for the Pathology Department and 7 years in consulting with KPMG and Pacific Strategy Partners. They earned an MBA with honors from the University of St. Gallen and were a scholarship PhD candidate in Biochemistry and Molecular Biology at Monash University. David is also a Graduate of the Australian Institute of Company Directors (GAICD).